2.200
+4,76%
2026-10-16
Fundamental Analysis
28 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -250.1% | +4.7% | 2 / 3 | -86.9% | +2.38 pp | -26.57 pp | -0.9% | 1.00 | — | 94,2 | −86,9% | −25,9 | −273,8% | — | 6.25 | — |
| Pts | 0 | 0 | 8 | 0 | 8 | 0 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 2.200 (close price on 2026-10-16)EPS (TTM): −131,3
Financial charts
1.Revenue & growth
VND bn94,2Q2/26
1.Revenue & growth
VND bn94,2Q2/26
2.Profit & growth
VND bn-25,6Q2/26
3.Profit mix (Penman)
VND bn-9,11Q2/26
4.Margins & cost structure
%4.2%Q2/26
5.Returns & cash cycle
% · days1.9%Q2/26
6.Earnings quality & cash
VND bn8,57Q2/26
7.Asset structure
VND bn2.379Q2/26
8.Funding & debt health
VND bn · times2.379Q2/26
9.Revenue backlog
VND bn0,35Q2/26
10.Valuation
times · %-19,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-327Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26